Amphastar Pharmaceuticals, Inc. (AMPH): Price and Financial Metrics

AMPH POWR Grades

• Growth is the dimension where AMPH ranks best; there it ranks ahead of 96.18% of US stocks.
• AMPH's strongest trending metric is Momentum; it's been moving down over the last 47 weeks.
• AMPH ranks lowest in Momentum; there it ranks in the 14th percentile.

AMPH Stock Summary

• With a price/earnings ratio of 82.38, Amphastar Pharmaceuticals Inc P/E ratio is greater than that of about 90.17% of stocks in our set with positive earnings.
• In terms of twelve month growth in earnings before interest and taxes, Amphastar Pharmaceuticals Inc is reporting a growth rate of 154.89%; that's higher than 86.18% of US stocks.
• The volatility of Amphastar Pharmaceuticals Inc's share price is greater than that of merely 8.2% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to Amphastar Pharmaceuticals Inc, a group of peers worth examining would be QUIK, DYAI, PSNL, CERS, and MTSI.
• AMPH's SEC filings can be seen here. And to visit Amphastar Pharmaceuticals Inc's official web site, go to www.amphastar.com.

AMPH Valuation Summary

• AMPH's EV/EBIT ratio is 46.7; this is 59.39% higher than that of the median Healthcare stock.
• AMPH's EV/EBIT ratio has moved up 19.7 over the prior 87 months.
• Over the past 87 months, AMPH's price/sales ratio has gone up 0.8.

Below are key valuation metrics over time for AMPH.

AMPH Growth Metrics

• The year over year net income to common stockholders growth rate now stands at -95.2%.
• The 2 year net income to common stockholders growth rate now stands at 1532.66%.
• Its 5 year price growth rate is now at 37.99%.

Over the past 15 months, AMPH's revenue has gone up $56,780,000.

The table below shows AMPH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	384.035	80.684	10.454
2021-03-31	368.178	78.614	2.495
2020-12-31	349.846	57.266	1.403
2020-09-30	337.308	46.025	6.65
2020-06-30	334.014	25.215	4.041
2020-03-31	327.255	46.849	52.02

AMPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AMPH has a Quality Grade of C, ranking ahead of 66.26% of graded US stocks.
• AMPH's asset turnover comes in at 0.601 -- ranking 57th of 677 Pharmaceutical Products stocks.
• VTVT, MTEX, and BBI are the stocks whose asset turnover ratios are most correlated with AMPH.

The table below shows AMPH's key quality metrics over time.